Bioss Antibodies

Presenting antibody-related research at a 2026 conference? Bioss is launching our 2026 Travel Grants to help get your research there! Submit your abstract here for a chance to win: hubs.ly/Q046ZWRr0 Which conference is at the top of your list for 2026?

Working on Nipah virus studies? See our latest blog and explore Nipah virus-related recombinant proteins now available from Bioss. View here: hubs.ly/Q040Wbc90

If you’re choosing between antibodies, citation history is often the fastest way to estimate: 🔬 success probability 📉 experimental risk 🧪 reviewer confidence Read the full breakdown in our new blog 👇 hubs.ly/Q040qZZG0

Join the Bioss team at Booth 2318 to explore our latest solutions for neuroscience research at NEUROSCIENCE 2025!

In the landscape of biomedical research, few methodologies have reshaped our comprehension of disease pathogenesis as fundamentally as immunohistochemistry; this technique has become a cornerstone of diagnostic and investigative pathology. Read here: hubs.ly/Q03R8VmG0

👉 Download your free booklet now and bring clarity and confidence to every IHC experiment: hubs.ly/Q03N-xsc0

This month’s IHC spotlight features bsm-60737R (CD11b), bsm-54767R (CD44), bsm-54132R (AIF1), and bsm-52455R (Ki-67)— critical markers for tracking immune activation, inflammation, microglial response, and cell proliferation. Visit hubs.ly/Q03NZWQc0 to learn more.

Whether you’re optimizing assays or refining your staining protocols, HRP polymer detection offers the precision and sensitivity needed to elevate your IHC results. Explore how it works and why it’s redefining immunohistochemistry: hubs.ly/Q03Ny5-r0.

We're here to help you stretch your grant funding further with our Best Price offer! Take the most of your research budget now and submit a comparable lower-priced item to us for a discount to apply on your order! 🔗 hubs.ly/Q03JQ-vG0

AI is transforming in vitro diagnostics (IVD) by accelerating the discovery and optimization of antibody pairs for ELISA, lateral flow assays, and multiplex platforms. Read here: hubs.ly/Q03JxZXG0

A new study in Alzheimer’s & Dementia shows that drugs already used for Parkinson’s disease may improve memory and cognition in Alzheimer’s patients. Could targeting dopamine be the next breakthrough for Alzheimer’s? Learn more here: hubs.ly/Q03H8DK10

Recombinant Proteins, Refined for Your Research 🧬 With 9,000+ recombinant proteins available, Bioss supports early discovery to large-scale workflows— without compromising performance. Explore the collection: hubs.ly/Q03B01km0

Bioss Knockdown-Validated Recombinant Antibodies are paired with matched lysates for enhanced reliability and better signal specificity. Explore our portfolio designed to boost confidence in your results here: hubs.ly/Q03GGgmM0

For a limited-time only: Receive 20% off Bioss Conjugated Antibodies! Search your targets of interest here: hubs.ly/Q03GGdcy0.

Whether you're outfitting a core lab or running a single project, every dollar counts. We're here to help you stretch your grant funding further— but this limited-time offer won't be around much longer... make the most of your research budget now! 🔗 hubs.ly/Q03z_YWq0

Antibodies power modern research—but not all antibodies are created equal. Batch-to-batch variability can make or break results, which is why researchers are increasingly asking: Should I use recombinant monoclonal antibodies or polyclonals? 🔗 Read here: hubs.ly/Q03FsBPG0

Bioss Knockdown-Validated Recombinant Antibodies are paired with matched lysates for enhanced reliability and better signal specificity. Explore our portfolio designed to boost confidence in your results here: hubs.ly/Q03FsqlD0

For a limited-time only: Receive 20% off Bioss Conjugated Antibodies! Search your targets of interest here: hubs.ly/Q03Fsqmv0.

Now available...AbBy Fluor™ NHS Esters for consistent, high-quality labeling! View here: hubs.ly/Q03z_ZF50

Discover Bioss' collection of antibodies for mitochondrial markers: hubs.ly/Q03z_ZjF0